TrialAssure has announced the release of TrialAssure LINK software for the development, review, translation and publishing of plain language, or lay summaries.
Key features of LINK include the ability to:
TrialAssure LINK is a core application within The Ultimate Transparency Suite along with existing applications that include TrialAssure REGISTRY, TrialAssure ANONYMIZE, and TrialAssure BEACON.
For more information, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.